Neuronetics
Stock
Stock
Ticker: STIM
STIM
Price
Price
CHART BY
Frequently asked questions
What is Neuronetics's market capitalization?
The market capitalization of Neuronetics is $150.87M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Neuronetics?
Neuronetics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.441. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Neuronetics's stock?
Currently, 4 analysts cover Neuronetics's stock, with a consensus target price of $5.75. Analyst ratings provide insights into the stock's expected performance.
What is Neuronetics's revenue over the trailing twelve months?
Over the trailing twelve months, Neuronetics reported a revenue of $155.10M.
What is the EBITDA for Neuronetics?
Neuronetics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$19.73M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Neuronetics?
Neuronetics has a free cash flow of -$11.31M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Neuronetics have, and what sector and industry does it belong to?
Neuronetics employs approximately 658 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Neuronetics's shares?
The free float of Neuronetics is 28.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $150.87M
- EPS (TTM)
- -$0.441
- Free Float
- 28.88M
- Revenue (TTM)
- $155.10M
- EBITDA (TTM)
- -$19.73M
- Free Cashflow (TTM)
- -$11.31M
Pricing
- 1D span
- $1.937$2.019
- 52W span
- $0.80$3.44
Analyst Ratings
The price target is $5.75 and the stock is covered by 4 analysts.
Buy
4
Hold
0
Sell
0
Information
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.
- Employees
- 658
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- STIM
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet